For example, the checklist published by King and Lam (2019) would suggest DLBCL, NOS as an appropriate diagnosis for our patient, given that his cancer was a cyclin-D1-, CD10+, BCL6-, lymphoid, large B-cell lesion with a high labeling of Ki-67 [9]. This evidence concerns the gene CCND1 and diffuse large B-cell lymphoma.